Literature DB >> 22369946

Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.

Qingna Zhai1, Liang Zhou, Chunjuan Zhao, Jun Wan, Zhendong Yu, Xin Guo, Jie Qin, Jing Chen, Ruijing Lu.   

Abstract

MicroRNAs (miRNAs) have emerged as powerful regulators of multiple processes linked to human cancer, including cell apoptosis, proliferation and migration, suggesting that the regulation of miRNA function could play a critical role in cancer progression. Recent studies have found that human serum/plasma contains stably expressed miRNAs. If they prove indicative of disease states, miRNAs measured from peripheral blood samples may be a source for routine clinical detection of cancer. Our studies showed that both miR-508-3p and miR-509-3p were down-regulated in renal cancer tissues. The level of miR-508-3p but not miR-509-3p in renal cell carcinoma (RCC) patient plasma demonstrated significant differences from that in control plasma. In addition, the overexpression of miR-508-3p and miR-509-3p suppressed the proliferation of RCC cells (786-0), induced cell apoptosis and inhibited cell migration in vitro. Our data demonstrated that miR-508-3p and miR-509-3p played an important role as tumor suppressor genes during tumor formation and that they may serve as novel diagnostic markers for RCC.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22369946     DOI: 10.1016/j.bbrc.2012.02.060

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  53 in total

1.  Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.

Authors:  Karina A Galoian; Toumy Guettouche; Biju Issac; Amir Qureshi; H T Temple
Journal:  Tumour Biol       Date:  2013-11-01

2.  Extensive miRNA expression analysis in craniopharyngiomas.

Authors:  Jill Samis; Elio F Vanin; Simone Treiger Sredni; Maria de Fátima de Bonaldo; Fabricio F Costa; Tadanori Tomita; Reema Habiby; Donald Zimmerman; Marcelo B Soares
Journal:  Childs Nerv Syst       Date:  2016-06-07       Impact factor: 1.475

3.  Upregulated miR-193a-3p as an oncogene in esophageal squamous cell carcinoma regulating cellular proliferation, migration and apoptosis.

Authors:  Yunfeng Yi; Jianming Chen; Changjie Jiao; Jing Zhong; Zhiming Song; Xiaoping Yu; Xiujuan Lu; Baoli Lin
Journal:  Oncol Lett       Date:  2016-10-05       Impact factor: 2.967

4.  Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.

Authors:  Ruijing Lu; Ziliang Ji; Xiaoqing Li; Jie Qin; Guanghui Cui; Jing Chen; Qingna Zhai; Chunjuan Zhao; Wei Zhang; Zhendong Yu
Journal:  Tumour Biol       Date:  2015-03-27

5.  Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma.

Authors:  Yunfeng Yi; Xiujuan Lu; Jianming Chen; Changjie Jiao; Jing Zhong; Zhiming Song; Xiaoping Yu; Baoli Lin
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

6.  MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.

Authors:  Xiaotang Yu; Xinchen Zhang; Tie Bi; Yanfang Ding; Jinyao Zhao; Chang Wang; Tingting Jia; Dan Han; Gordon Guo; Bo Wang; Jiyong Jiang; Shiying Cui
Journal:  Tumour Biol       Date:  2013-07-09

7.  MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1.

Authors:  Cai Lv; Zhiming Bai; Zhenxiang Liu; Pengcheng Luo; Jie Zhang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 8.  The regulation and function of microRNAs in kidney diseases.

Authors:  Qingqing Wei; Qing-Sheng Mi; Zheng Dong
Journal:  IUBMB Life       Date:  2013-07       Impact factor: 3.885

9.  Identification of miR-7 as an oncogene in renal cell carcinoma.

Authors:  Zuhu Yu; Liangchao Ni; Duqun Chen; Qiang Zhang; Zhengming Su; Yadong Wang; Wenshui Yu; Xionghui Wu; Jiongxian Ye; Shangqi Yang; Yongqing Lai; Xianxin Li
Journal:  J Mol Histol       Date:  2013-06-21       Impact factor: 2.611

Review 10.  Metabolism of kidney cancer: from the lab to clinical practice.

Authors:  Sunil Sudarshan; Jose A Karam; James Brugarolas; R Houston Thompson; Robert Uzzo; Brian Rini; Vitaly Margulis; Jean-Jacques Patard; Bernard Escudier; W Marston Linehan
Journal:  Eur Urol       Date:  2012-09-28       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.